GL1X · GenesisL1 explorer

MolNFT v1 · #183762 · protein

X-ray structure of SMYD3 in complex with benzodiazepine-type inhibitor 6

7O2B · Histone-lysine N-methyltransferase SMYD3: “X-ray structure of SMYD3 in complex with benzodiazepine-type inhibitor 6”. X-ray diffraction, 3 ligands (UZQ, SAM, ZN), 5 pockets (best druggability 0.78). MolNFT v1 #183762 on GenesisL1…

PDB
7O2B
Type
protein
Length
427 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.354
UniProt
Q9H7B4
Ligands
UZQ, SAM, ZN
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354)protein42750% helix, 13% strandQ9H7B4

Ligands and binding sites

  • UZQ · (2S)-N-butyl-1-(2-fluorophenyl)carbonyl-2-methyl-4-oxidanylidene-3,5-dihydro-2H-1,5-benzodiazepine-7-carboxamide · ligand · chains A
  • SAM · S-adenosylmethionine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19470.780.8079UZQ
21570.580.8225SAM
31670.530.7934empty
4940.440.7921empty
5500.320.7711empty

Compared structures

  • 7O2B · X-RAY STRUCTURE OF SMYD3 in complex with benzodiazepine-type inhibitor 6 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.